BBV154 Archives

People above 18 years of age, with a vaccination history of more than five months but less than seven months are eligible to participate in the phase 3 trial

COVID_19

AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from...

PGurus Newsdesk - March 10, 2022 0

AIIMS Delhi to start clinical trials of Bharat Biotech’s intranasal booster vaccine All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials...

As against injectable vaccines, intranasal vaccine is claimed to be easy to administer during mass inoculation campaigns

COVID_19

Bharat Biotech gets a nod from DGCI for phase 3 trials...

PGurus Newsdesk - January 5, 2022 0

Bharat Biotech gets SEC approval for phase 3 clinical trials of nasal vaccine as a booster shot As India stares at the third wave of...

Increasing the Covaxin shelf life helps reduce the carbon footprint, says the company

Health

Shelf life of Covaxin extended to 12 months from the date...

Team PGurus - December 20, 2021 1

Extended shelf-life for Covaxin helps lessen vaccine wastage The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's...